The global drug discovery informatics market is entering a high-growth phase as pharmaceutical and biotechnology companies increasingly shift from conventional research workflows toward computational, data-driven drug development. The industry was valued at US$4.8 Bn in 2025 and is estimated to advance at a 10.8% CAGR from 2026 to 2036, reaching approximately US$15.1 Bn by the end of 2036.👉 Get...
